Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study

Objective: To compare the outcomes of transarterial chemoembolization (TACE) combined with sorafenib versus TACE alone for treating patients with unresectable hepatocellular carcinoma (HCC). Methods: This retrospective analysis included all patients receiving either TACE plus sorafenib therapy or TA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cancer
Asıl Yazarlar: Ren, Baosheng, Wang, Wansheng, Shen, Jian, Li, Wanci, Ni, Caifang, Zhu, Xiaoli
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2019
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400692/
https://ncbi.nlm.nih.gov/pubmed/30854128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.28994
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller